GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Curocell Inc (XKRX:372320) » Definitions » Accumulated other comprehensive income (loss)

Curocell (XKRX:372320) Accumulated other comprehensive income (loss) : ₩0.00 Mil (As of Jun. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Curocell Accumulated other comprehensive income (loss)?

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. Curocell's Accumulated other comprehensive income (loss) for the quarter that ended in Jun. 2023 was ₩0.00 Mil.


Curocell Accumulated other comprehensive income (loss) Historical Data

The historical data trend for Curocell's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curocell Accumulated other comprehensive income (loss) Chart

Curocell Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Accumulated other comprehensive income (loss)
- - - - -

Curocell Semi-Annual Data
Jun22 Dec22 Jun23 Dec23
Accumulated other comprehensive income (loss) - - - -

Curocell Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.


Curocell Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of Curocell's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.


Curocell (XKRX:372320) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Curocell Inc (XKRX:372320) » Definitions » Accumulated other comprehensive income (loss)
Comparable Companies
Traded in Other Exchanges
N/A
Address
11, Gukjegwahak 16-ro, Yuseong-gu, Daejeon, KOR, 34002
Curocell Inc is engaged in medical and pharmaceutical research and development. The company is into development of CAR-T treatments that enhance the natural function of immune cells to eliminate cancer cells through genetic manipulation of human immune cells.

Curocell (XKRX:372320) Headlines

No Headlines